Category — Healthcare
Hewlett Packard along with Narayana Health has been running cloud-enabled portable eHealth centers in rural India. These are built in shipping containers and placed in states such as Uttar Pradesh, where thousands of people are being given medical aid.
These containers are easy to transport and are equipped to deliver quality and affordable healthcare services to people living in areas, where finding the right kind of health care is otherwise a distant dream. These eHealth containers are built to connect patients in remote areas to receive healthcare from the urban doctors Each container is fully equipped with cloud-integrated diagnostics equipment, HP workstations and video conferencing material.
HP will be heading to more Tier-2 and Tier-3 cities in the country and expand this health initiative. The organization plans to install up to 20 more eHealth centres in India, over the next 18-20 months.
July 26, 2014 No Comments
Blue chip Silicon Valley venture fund Sequoia Capital has had a presence on the ground in India for over a decade. Now it has announced a new $530 million fund which whose focus will include healthcare in India. To make this possible, Sequoia Capital India Advisors has assembled an internal team of 10 executives to help founders of portfolio companies with support in the legal, finance, marketing, human resources, information technology, business development and engineering divisions. Sequoia Capital is invested in more than 75 companies including Just Dial, handset maker Micromax Informatics Ltd, and Vasan Eye Care Ltd.
Within healthcare, the firm invests across diagnostic services, genetics services, lab services, patient services, product development services, and enabling technology companies. While Sequoia is best know for technology successes such as Apple, Cisco, Google, What’s App and Yahoo, the fund has had a deep interest in healthcare and sees India as a new frontier for healthcare related startups. It’s current healthcare investments include Health Catalyst, a tech platform that organizes and links health-related data from different systems and Natera which develops tests ranging from pre-implantation genetic diagnosis for IVF to advances in the field of non-invasive prenatal testing
“The two trends that we have been seeing is that mobile Internet is growing, and Indian start-ups are increasingly becoming global. We want to tap both these opportunities,” said Shailendra Singh, managing director Sequoia Capital. The fund’s India offices are located in Bangalore.
July 26, 2014 No Comments
While Johnson & Johnson’s Cordis withdrew from India, companies such as Abbott Laboratories – Vascular, Boston Scientific Corporation, Medtronic Inc. and other players like Biotronik, Sahajanand Medical Technologies, Meril Life Sciences and Translumina Therapeutics are vying to expand their presence in India through investments in the coronary stent market, according to a research report. Stent sales in India approach half a billion dollars annually according to this report, a number that seems high to the The India Expert. However we do expect double digit growth in India for the next decade.
Boston Scientific Corporation is strengthening its presence in the emerging nations with Brazil, Russia, India and China (BRIC) and recorded 22% growth rate in these countries in the last quarter. Medtronic management is targeting 20% of its revenues from the emerging market eyeing incremental revenues of $2.5 billion over the next 5 years (and this was before the proposed merger with Covidien).
July 25, 2014 No Comments
Further developing its capabilities in India, Covidien PLC has opened a training and education center in India. Quoted in MarketNews Brian D. King, President Emerging Markets said “The Covidien Center of Innovation India in Mumbai offers clinicians training on advanced procedures and techniques using leading equipment and technology.
The top three priorities will be procedures to address vascular disease, metabolic disorders (obesity and Type II diabetes) and cancer. Mark Rooney, Managing Director, India Subcontinent, Covidien, said, “Chronic diseases contribute to over half of Indian deaths. Cardiovascular disease, dyslipidemia and many types of cancers are highly prevalent in urban and rural areas. The India center will have the capacity to train more than 5,000 healthcare professionals annually
Covidien has an important and growing presence in India with offices in Gurgaon, Mumbai, Chennai, Kolkata and Hyderabad. The company has more than 400 employees in India with a network of distributors and partner hospitals across the country. In 2012, Covidien opened the Covidien India Engineering Center, in Hyderabad. (Full Disclosure: The company is an Amritt client. This article is derived exclusively from public sources).
April 30, 2014 No Comments
GE Healthcare is jointly investing $130 million with Pennsylvania based Cancer Treatment Services International (CTSI) to set up a chain of 25 cancer detection and treatment centers across India. GE will provide equipment while CTSI, which set up the 250-bed American Oncology Institute in Hyderabad in 2012, will take care of treatment, doctors, medical personnel and related services.
GE Healthcare will be the minority investor, its Chairman and CEO John Dineen told a joint news conference. According to Dineen, the partnership was a part of its $1-billion commitment to R&D related to diagnosing cancer. GE is also developing low-cost diagnostic technologies ‘in India and for India’ for various diseases, 100 of them targeting cancer alone. It recently launched a low-cost version of PET-CT that is widely used to find cancerous tumors.
Terri Bresenham, Bangalore-based President and CEO of GE Healthcare South Asia, said cancer cases, now at three million, were rising sharply in India, and a large number of its victims were dying due to late detection and high cost of treatment. Also, 1.23 million new cases were showing up each year. CTSI President and CEO Joe Nicholas said the partners planned to start the first few centers in Andhra Pradesh as a hub-and-spoke model, and later try it out in other countries that have similar conditions. The $10-million Hyderabad location has already treated 10,000 people.
What this means
Setting up long-term win-win models may be a good way to enter and expand. India also serves as a crucible to prove out models that can apply in the developing nations of Africa, South America and Asia.
April 30, 2014 No Comments